Suggestions
Journal Information
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
Cite
Cite
Share
Download PDF
More article options
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
473
Full text access

EPSTEIN–BARR VIRUS (EBV) ENCEPHALITIS IN A KIDNEY TRANSPLANT RECIPIENT – CASE REPORT

Visits
908
Tathyanna Bichara de Souza Neves
Corresponding author
ta.bichara@gmail.com

Corresponding author:
, Alberto dos Santos de Lemos, Guilherme Santoro Lopes, Talita Mourão Chaves Corriça Loyola, Márcia Halpern
Hospital Universitário Clementino Fraga Filho (HUCFF), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 30. Issue S1

XXIV Brazilian Congress of Infectious Diseases 2025

More info
Introduction

In solid organ transplant (SOT) recipients, EBV infection is usually associated with post-transplant lymphoproliferative disease. Central nervous system manifestations are rare clinical entities, generally resulting from reactivation of latent EBV in the recipient due to intense immunosuppression, especially in the first months after transplantation.

Case report

A 62-year-old female patient with hypertension underwent deceased-donor kidney transplant in 2002 and was on immunosuppression with mycophenolate mofetil, prednisone and tacrolimus. She was admitted with anuria, malaise, diarrhea and nausea/vomiting, and was diagnosed with urinary tract infection due to ESBL-producing E. coli and hyponatremia secondary to SIADH. During hospitalization, she developed bilateral frontal headache of progressively increasing intensity, refractory to analgesics, and somnolence. Physical examination showed no focal deficits or signs of meningeal irritation. Cranial CT was unremarkable. Lumbar puncture showed clear CSF, normal opening pressure, pleocytosis with lymphocytic predominance, elevated protein, and normal glucose and lactate. CrAg, VDRL, direct mycological exam, AFB smear and cultures for common germs, fungi and mycobacteria were negative. A multiplex PCR panel for herpesviruses confirmed EBV encephalitis. Ganciclovir was given for 21 days, with progressive symptom improvement. The following year, she was readmitted with vomiting, fever up to 38°C, anorexia and decreased level of consciousness. She was initially diagnosed with graft pyelonephritis due to K. pneumoniae, with only partial clinical and laboratory response despite appropriate antibiotic therapy. Lumbar puncture showed CSF pleocytosis and elevated protein; quantitative EBV PCR was 31,000 copies/million cells in CSF and 133 copies/mL in plasma. A course of ganciclovir was administered and immunosuppressant doses were reduced; at the end of treatment, the patient made a complete recovery and EBV viral load became undetectable in both CSF and plasma.

Conclusion

EBV encephalitis in SOT recipients is rarely reported in the literature and is difficult to distinguish clinically from other causes of infectious encephalopathy, making molecular tools essential for diagnosis. Reducing immunosuppression and initiating antiviral therapy are key to reducing neurologic sequelae and mortality.

Keywords:
EBV
Encephalitis
Kidney Transplant
PDF
Full text is only available in PDF
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools